Cargando…

Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships

Thiosemicarbazones (TSCs) are an interesting class of ligands that show a diverse range of biological activity, including anti-fungal, anti-viral and anti-cancer effects. Our previous studies have demonstrated the potent in vivo anti-tumor activity of novel TSCs and their ability to overcome resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Serda, Maciej, Kalinowski, Danuta S., Rasko, Nathalie, Potůčková, Eliška, Mrozek-Wilczkiewicz, Anna, Musiol, Robert, Małecki, Jan G., Sajewicz, Mieczysław, Ratuszna, Alicja, Muchowicz, Angelika, Gołąb, Jakub, Šimůnek, Tomáš, Richardson, Des R., Polanski, Jaroslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199632/
https://www.ncbi.nlm.nih.gov/pubmed/25329549
http://dx.doi.org/10.1371/journal.pone.0110291
_version_ 1782339944657715200
author Serda, Maciej
Kalinowski, Danuta S.
Rasko, Nathalie
Potůčková, Eliška
Mrozek-Wilczkiewicz, Anna
Musiol, Robert
Małecki, Jan G.
Sajewicz, Mieczysław
Ratuszna, Alicja
Muchowicz, Angelika
Gołąb, Jakub
Šimůnek, Tomáš
Richardson, Des R.
Polanski, Jaroslaw
author_facet Serda, Maciej
Kalinowski, Danuta S.
Rasko, Nathalie
Potůčková, Eliška
Mrozek-Wilczkiewicz, Anna
Musiol, Robert
Małecki, Jan G.
Sajewicz, Mieczysław
Ratuszna, Alicja
Muchowicz, Angelika
Gołąb, Jakub
Šimůnek, Tomáš
Richardson, Des R.
Polanski, Jaroslaw
author_sort Serda, Maciej
collection PubMed
description Thiosemicarbazones (TSCs) are an interesting class of ligands that show a diverse range of biological activity, including anti-fungal, anti-viral and anti-cancer effects. Our previous studies have demonstrated the potent in vivo anti-tumor activity of novel TSCs and their ability to overcome resistance to clinically used chemotherapeutics. In the current study, 35 novel TSCs of 6 different classes were designed using a combination of retro-fragments that appear in other TSCs. Additionally, di-substitution at the terminal N4 atom, which was previously identified to be critical for potent anti-cancer activity, was preserved through the incorporation of an N4-based piperazine or morpholine ring. The anti-proliferative activity of the novel TSCs were examined in a variety of cancer and normal cell-types. In particular, compounds 1d and 3c demonstrated the greatest promise as anti-cancer agents with potent and selective anti-proliferative activity. Structure-activity relationship studies revealed that the chelators that utilized “soft” donor atoms, such as nitrogen and sulfur, resulted in potent anti-cancer activity. Indeed, the N,N,S donor atom set was crucial for the formation of redox active iron complexes that were able to mediate the oxidation of ascorbate. This further highlights the important role of reactive oxygen species generation in mediating potent anti-cancer activity. Significantly, this study identified the potent and selective anti-cancer activity of 1d and 3c that warrants further examination.
format Online
Article
Text
id pubmed-4199632
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41996322014-10-21 Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships Serda, Maciej Kalinowski, Danuta S. Rasko, Nathalie Potůčková, Eliška Mrozek-Wilczkiewicz, Anna Musiol, Robert Małecki, Jan G. Sajewicz, Mieczysław Ratuszna, Alicja Muchowicz, Angelika Gołąb, Jakub Šimůnek, Tomáš Richardson, Des R. Polanski, Jaroslaw PLoS One Research Article Thiosemicarbazones (TSCs) are an interesting class of ligands that show a diverse range of biological activity, including anti-fungal, anti-viral and anti-cancer effects. Our previous studies have demonstrated the potent in vivo anti-tumor activity of novel TSCs and their ability to overcome resistance to clinically used chemotherapeutics. In the current study, 35 novel TSCs of 6 different classes were designed using a combination of retro-fragments that appear in other TSCs. Additionally, di-substitution at the terminal N4 atom, which was previously identified to be critical for potent anti-cancer activity, was preserved through the incorporation of an N4-based piperazine or morpholine ring. The anti-proliferative activity of the novel TSCs were examined in a variety of cancer and normal cell-types. In particular, compounds 1d and 3c demonstrated the greatest promise as anti-cancer agents with potent and selective anti-proliferative activity. Structure-activity relationship studies revealed that the chelators that utilized “soft” donor atoms, such as nitrogen and sulfur, resulted in potent anti-cancer activity. Indeed, the N,N,S donor atom set was crucial for the formation of redox active iron complexes that were able to mediate the oxidation of ascorbate. This further highlights the important role of reactive oxygen species generation in mediating potent anti-cancer activity. Significantly, this study identified the potent and selective anti-cancer activity of 1d and 3c that warrants further examination. Public Library of Science 2014-10-16 /pmc/articles/PMC4199632/ /pubmed/25329549 http://dx.doi.org/10.1371/journal.pone.0110291 Text en © 2014 Serda et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Serda, Maciej
Kalinowski, Danuta S.
Rasko, Nathalie
Potůčková, Eliška
Mrozek-Wilczkiewicz, Anna
Musiol, Robert
Małecki, Jan G.
Sajewicz, Mieczysław
Ratuszna, Alicja
Muchowicz, Angelika
Gołąb, Jakub
Šimůnek, Tomáš
Richardson, Des R.
Polanski, Jaroslaw
Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
title Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
title_full Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
title_fullStr Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
title_full_unstemmed Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
title_short Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
title_sort exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199632/
https://www.ncbi.nlm.nih.gov/pubmed/25329549
http://dx.doi.org/10.1371/journal.pone.0110291
work_keys_str_mv AT serdamaciej exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT kalinowskidanutas exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT raskonathalie exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT potuckovaeliska exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT mrozekwilczkiewiczanna exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT musiolrobert exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT małeckijang exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT sajewiczmieczysław exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT ratusznaalicja exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT muchowiczangelika exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT gołabjakub exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT simunektomas exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT richardsondesr exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships
AT polanskijaroslaw exploringtheanticanceractivityofnovelthiosemicarbazonesgeneratedthroughthecombinationofretrofragmentsdissectionofcriticalstructureactivityrelationships